scholarly journals Auditory Interneurones in the Metathoracic Ganglion of the Grasshopper Chorthippus Biguttulus: II. Processing of Temporal Patterns of the Song of the Male

1991 ◽  
Vol 158 (1) ◽  
pp. 411-430 ◽  
Author(s):  
ANDREAS STUMPNER ◽  
BERNHARD RONACHER ◽  
OTTO VON HELVERSEN
Keyword(s):  
Response Curve ◽  
Temporal Patterns ◽  
Behavioural Response ◽  
Complete Inhibition ◽  
Similar Response ◽  
Sound Direction ◽  
Intensity Range ◽  
Metathoracic Ganglion ◽  
Chorthippus Biguttulus

1. Auditory interneurones originating in the metathoracic ganglion of females of the grasshopper Chorthippus biguttulus were investigated with respect to their processing of models of the male's song. In these models two temporal configurations were varied: (i) the song pattern, consisting of ‘syllables’ and ‘pauses’, and (ii) the duration of short gaps within syllables. 2. A precise encoding of the song pattern is found only among receptors and ‘thoracic’ neurones (SN1, TNI), but not among ascending neurones. The only ascending neurone that reacts tonically at all intensities (AN6) encodes the song pattern much less precisely than do receptors. Other ascending neurones (AN3, AN11) encode the gross pattern of model songs, but only at low intensities. 3. One spontaneously active ‘local’ neurone (SN6) is tonically inhibited and encodes the pauses of a model song. A similar response, however, is not found in three ascending neurones (AN13, AN14, AN15), which are merely inhibited. 4. Among ascending neurones, AN12 is the most reliably influenced by the syllable-pause structure of the songs. Its phasic burst marks the onset of every syllable in a behaviourally attractive song. Its activity could account for the rising part of the corresponding behavioural response curve. However, no ascending neurone shows activity corresponding to the falling part of the behavioural response. Among local neurones, the phasic BSN1 neurones are most clearly influenced by varying syllable-pause combinations. 5. Gaps within the song syllables cause a complete inhibition of the activity of AN4. The response of AN4 to syllables with and without gaps is strikingly similar to the behavioural response and is maintained over the whole intensity range tested. Several local neurones, especially SN6, are strongly influenced by gaps within model songs - though only in certain intensity ranges. 6. In accordance with behavioural results, the pathways for information on song pattern and sound direction appear to be separated among ascending neurones. Among local interneurones, however, this separation does not appear to take place, since the most directional local neurone, BSN1, might also be suited for pattern-filtering tasks.

Auditory Interneurones in the Metathoracic Ganglion of the Grasshopper Chorthippus Biguttulus: I. Morphological and Physiological Characterization

1991 ◽  
Vol 158 (1) ◽  
pp. 391-410 ◽  
Author(s):  
ANDREAS STUMPNER ◽  
BERNHARD RONACHER
Keyword(s):  
White Noise ◽  
Dynamic Range ◽  
Lucifer Yellow ◽  
Physiological Characterization ◽  
Acoustic Stimuli ◽  
Physiological Properties ◽  
Metathoracic Ganglion ◽  
Branching Patterns ◽  
Dependent Inhibition ◽  
Chorthippus Biguttulus

1. Auditory intemeurones originating in the metathoracic ganglion of females of the grasshopper Chorthippus biguttulus can be classified as local (SN), bisegmental (BSN), T-shaped (TN) and ascending neurones (AN). A comparison of branching patterns and physiological properties indicates that auditory interneurones of C. biguttulus are homologous with those described for the locust. 2. Eighteen types of auditory neurones are morphologically characterized on the basis of Lucifer Yellow staining. All of them branch bilaterally in the metathoracic ganglion. Smooth dendrites, from which postsynaptic potentials (PSPs) can be recorded, predominate on the side ipsilateral to the soma. If ‘beaded’ branches exist, they predominate contralaterally. The ascending axon runs contralaterally to the soma, except in T-fibres. 3. Auditory receptors respond tonically. The dynamic range of their intensity-response curve covers 20–25 dB. Local, bisegmental and T-shaped neurones are most sensitive to stimulation ipsilateral to the soma. The responses of SN1 and TNI to white-noise stimuli are similar to those of receptors, while phasic-tonic responses are found in SN4, SN5, SN7 and BSN1. The bisegmental neurones receive side-dependent inhibition that corresponds to a 20–30dB attenuation. One local element (SN6) is predominantly inhibited by acoustic stimuli. 4. Ascending neurones are more sensitive to contralateral stimulation (i.e. on their axon side). Only one of them (AN6) responds tonically to white-noise stimuli at all intensities; others exhibit a tonic discharge only at low or at high intensities.One neurone (AN12) responds with a phasic burst over a wide intensity range. The most directional neurones (AN1, AN2) are excited by contralateral stimuli and (predominantly) inhibited by ipsilateral stimuli. Three ascending neurones (AN13-AN15) are spontaneously active and are inhibited by acoustic stimuli. 5. All auditory intemeurones, except SN5, are more sensitive to pure tones below 10 kHz than to ultrasound.

Personalizing Therapies With Ex Vivo Pharmacological Responses May Uncover The Differences Between IDA-DNR-MIT Among European AML Protocols

Blood ◽  
2013 ◽  
Vol 122 (21) ◽  
pp. 1294-1294
Author(s):  
Pau Montesinos ◽  
David Martinez ◽  
Raimundo Garcia Boyero ◽  
Jaime Pérez de Oteyza ◽  
Pascual Fernandez ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Flow Cytometry ◽  
Clinical Trials ◽  
Dose Response ◽  
Response Curve ◽  
Ex Vivo ◽  
Dose Response Curve ◽  
Differential Sensitivity ◽  
Similar Response ◽  
Malignant Cells

Abstract Background and objectives Protocols for acute myeloid leukemia (AML) 1st line patients are centered on the combination of Cytarabine and an anthracycline; Idarubicin (IDA), Daunorubicin (DNR), or Mitoxantrone (MIT). Patients may be treated with IDA, DNR, or MIT depending on the country of residence, because multiple clinical trials have not found significant differences among them. A new Personalized Medicine (PM) test developed by Vivia Biotech based on pharmacological responses in patient samples (ex vivo) is uncovering individual responses to these treatments. Our objective is to explore whether a significant % of individual patients may respond differently to IDA vs DNR vs MIT treatments, in spite that of their “on average” similar response shown by clinical trials. Patients and Methods Multicenter, prospective, non-interventional study of the PETHEMA group for treatment of AML. Bone Marrow (BM) samples were collected at diagnosis for 160 AML patients. Samples were incubated for 48 hours in 96-well plates, each well containing different drugs or drug combinations, each at 8 different concentrations, enabling calculation of dose response curves for each single drug (CYT, IDA, DNR, MIT) and combination used in treatments (CYT-IDA, CYT-DNR, CYT-MIT). Drug response was evaluated as depletion of AML malignant cells in each well after 48 hours incubations. Annexin V-FITC was used to quantify the ability of the drugs to induce apoptosis. Malignant cells were identified with monoclonal antibodies and light scatter properties. 1) We use the whole bone marrow sample, retaining the erythrocyte population and serum proteins, during the entire incubation period; and after 48 h leukocytes are isolated prior to evaluation by flow cytometry. 2) We have pioneered development of a proprietary automated flow cytometry platform called ExviTech. 3) Pharmacological responses are calculated using pharmacokinetic population models. Results Figure left panel shows dose responses for both IDA (red) and DNR (blue) in 125 AML patient samples. Although their average curves (thick red & blue) are similar, the interpatient variability of either drug is quite large. We hypothesized that some patients could show very differential sensitivities to both drugs, as illustrated by the green arrow where a patient sample is resistant to DNR (right shifted dose response curve) but sensitive to IDA (left shifted dose response curve). To identify these cases Figure right panel shows a comparison of the potency IDA vs DNR. Potency is represented by their EC50 (concentration that kills 50% of the cells). Most dots tend to line up, but red dots represent patient samples with a difference in potency between these drugs >30%. Repeating this exercise for IDA-MIT and DNR-MIT to cover all alternatives among the 3 anthracyclines identifies 40% of patients samples with >30% different potency among IDA-DNR-MIT. Repeating this exercise with the combination treatments CYT-IDA, CYT-DNR, CYT-MIT increases to 58% the population of patients whose samples have a differential sensitivity to these anthracyclines. A fraction of this 57% of patients may benefit in if treatment selection among these 3 treatments were to be aided by this ex vivo testing sensitivities. To identify which fraction would benefit we would need a trial specifically designed. Conclusions This preliminary results show that Vivia's PM test seems able to identify a subset of AML patients who's ex vivo pharmacological response to anthracycline drugs is significantly different. Because this ex vivo test accurately predicts the clinical response to CYT-IDA, if these selective anthracycline ex vivo responses translate to clinical responses, a fraction of this 57% subpopulation could benefit significantly from receiving 1st or 2nd line treatments based on either IDA, DNR, MIT, and their combinations. Hence this approach stands for European integration of treatment protocols, based on ex vivo individual responses data rather than nationality. Disclosures: Primo: Vivia Biotech: Employment. Hernandez-Campo:Vivia Biotech: Employment. Rojas:Vivia Biotech: Employment. Bennett:Vivia Biotech: Employment. Liebana:Vivia Biotech: Employment. Lopez:Vivia Biotech: Employment. Ballesteros:Vivia Biotech: Equity Ownership.

Towards a Validation of Multiple Features in the Assessment of Emotions

1998 ◽  
Vol 14 (3) ◽  
pp. 202-210 ◽  
Author(s):  
Suzanne Skiffington ◽  
Ephrem Fernandez ◽  
Ken McFarland
Keyword(s):  
Factor Analysis ◽  
Pilot Study ◽  
Cognitive Appraisal ◽  
Negative Emotions ◽  
The Self ◽  
Factor Analyses ◽  
Data Set ◽  
Multiple Features ◽  
Action Tendency ◽  
Intensity Range

This study extends previous attempts to assess emotion with single adjective descriptors, by examining semantic as well as cognitive, motivational, and intensity features of emotions. The focus was on seven negative emotions common to several emotion typologies: anger, fear, sadness, shame, pity, jealousy, and contempt. For each of these emotions, seven items were generated corresponding to cognitive appraisal about the self, cognitive appraisal about the environment, action tendency, action fantasy, synonym, antonym, and intensity range of the emotion, respectively. A pilot study established that 48 of the 49 items were linked predominantly to the specific emotions as predicted. The main data set comprising 700 subjects' ratings of relatedness between items and emotions was subjected to a series of factor analyses, which revealed that 44 of the 49 items loaded on the emotion constructs as predicted. A final factor analysis of these items uncovered seven factors accounting for 39% of the variance. These emergent factors corresponded to the hypothesized emotion constructs, with the exception of anger and fear, which were somewhat confounded. These findings lay the groundwork for the construction of an instrument to assess emotions multicomponentially.

Does Viotin Activate Violin More Than Viocin?

2014 ◽  
Vol 61 (1) ◽  
pp. 23-29 ◽  
Author(s):  
Manuel Perea ◽  
Victoria Panadero
Keyword(s):  
Word Recognition ◽  
Visual Word Recognition ◽  
Developmental Dyslexia ◽  
Computational Models ◽  
Error Rates ◽  
Visual Word ◽  
Base Word ◽  
Similar Response ◽  
Skilled Readers ◽  
Young Readers

The vast majority of neural and computational models of visual-word recognition assume that lexical access is achieved via the activation of abstract letter identities. Thus, a word’s overall shape should play no role in this process. In the present lexical decision experiment, we compared word-like pseudowords like viotín (same shape as its base word: violín) vs. viocín (different shape) in mature (college-aged skilled readers), immature (normally reading children), and immature/impaired (young readers with developmental dyslexia) word-recognition systems. Results revealed similar response times (and error rates) to consistent-shape and inconsistent-shape pseudowords for both adult skilled readers and normally reading children – this is consistent with current models of visual-word recognition. In contrast, young readers with developmental dyslexia made significantly more errors to viotín-like pseudowords than to viocín-like pseudowords. Thus, unlike normally reading children, young readers with developmental dyslexia are sensitive to a word’s visual cues, presumably because of poor letter representations.

Temporal Patterns for Pitch and Loudness

1978 ◽  
Vol 23 (11) ◽  
pp. 856-857
Author(s):  
W. LAWRENCE GULICK
Keyword(s):  
Temporal Patterns

Temporal patterns of flow in the workplace

2013 ◽  
Author(s):  
J. Navarro ◽  
L. Ceja ◽  
J. Poppelbaum ◽  
D. Gomes
Keyword(s):  
Temporal Patterns

Factor VII Clotting Assay: Influence of Different Thromboplastins and Factor VII-Deficient Plasmas

1991 ◽  
Vol 65 (02) ◽  
pp. 160-164 ◽  
Author(s):  
Marina Poggio ◽  
Armando Tripodi ◽  
Guglielmo Mariani ◽  
Pier Mannuccio Mannucci ◽  
Keyword(s):  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Dose Response ◽  
Response Curve ◽  
Ischemic Heart ◽  
Factor Vii ◽  
Response Curves ◽  
Assay Sensitivity ◽  
Clinical Laboratories ◽  
Coagulant Activity

SummaryBeing a putative predictor of ischemic heart disease, the measurement of factor VII (FVTI) coagulant activity will be presumably requested to clinical laboratories with increasing frequency. To assess the influence on FVII assays of different thromboplastins and FVII-deficient plasmas we compared performances of all possible combinations of 5 thromboplastins and 6 deficient plasmas. The reproducibility of the clotting times of the dose-response curves for human and rabbit thromboplastins were acceptable (CV lower than 7%), whereas bovine thromboplastin had a higher CV. Reproducibility was very similar for all deficient plasmas when they were used in combination with a given thromboplastin. Responsiveness of the dose-response curve did not depend on the deficient plasma but rather on the thromboplastin: one rabbit thromboplastin was the least responsive, the bovine thromboplastin the most responsive, the human and the remaining two rabbit thromboplastins had intermediate responsiveness. Assay sensitivity to cold-activated FVII varied according to the thromboplastin: the bovine thromboplastin was the most sensitive, the human thromboplastin the least sensitive, of the three rabbit thromboplastins two were relatively sensitive, one was almost insensitive. In conclusion, our results indicate that thromboplastin rather than deficient plasma is the crucial factor in the standardization of FVII assay.

Synchronized Inhibition of the Phospholipid Mediated Autoactivation of Factor XII in Plasma by β2-glycoprotein I and Anti-β2-glycoprotein I

1995 ◽  
Vol 73 (05) ◽  
pp. 798-804 ◽  
Author(s):  
Inger Schousboe ◽  
Margit Søe Rasmussen
Keyword(s):  
Lupus Erythematosus ◽  
Lupus Anticoagulant ◽  
Response Curve ◽  
Inhibitory Effect ◽  
Factor Xii ◽  
High Antibody ◽  
Contact Activation ◽  
Maximal Inhibition ◽  
Lupus Anticoagulants ◽  
Glycoprotein I

SummaryLupus anticoagulants are a group of antibodies commonly found in patients with autoimmune diseases such as systemic lupus erythematosus. Lupus anticoagulants inhibit phospholipid dependent coagulation and may bind to negatively charged phospholipids. Recent studies have suggested an association between anti-β2-glycoprotein I and a lupus anticoagulant, whose activity is frequently dependent on the presence of β2-glycoprotein I. Based on these observations, the effect of anti-β2-glycoprotein I on the autoactivation of factor XII in plasma was investigated. Autoactivation initiated by the presence of negatively charged phospholipids, but not by sulfatide, was strongly inhibited by immunoaffinity purified anti-β2-glycoprotein I. The dose-response curve of anti-β2-gly coprotein I was identical with that of a precipitating antibody, showing no inhibition at low and high antibody dilutions and maximal inhibition at an intermediate dilution. At high antibody concentrations, an increased rate of factor Xlla activation was observed. This increase was of the same magnitude as the decreased rate observed in plasma supplemented with the same amount of β2-glycoprotein I as in the plasma itself. This confirms the inhibitory effect of β2-GP-I on the contact activation and shows that inhibition is effective on the autoactivation of factor XII in plasma. The inhibitory action of β2-glycoprotein I was independent of the inhibition caused by the anti- β2-glycoprotein I/β2-glycoprotein I complex suggesting a synchronized inhibition of factor XII autoactivation by β2-glycoprotein I and anti-β2-gly coprotein I. The inhibition caused by the antibody is suggested to be caused by a reduced availability of negatively charged phospholipids due to the binding of the anti-β2- GP-I/β2-GP-I complex. This complex may be a lupus anticoagulant.

Sign in / Sign up

Export Citation Format

Share Document